Virtus ETF Advisers’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Virtus ETF Advisers’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,061	Closed	-$656K	–	276
2018 Q1	$656K	Buy	10,061 +5,453	+118%	+$386K	0.57%	98
2017 Q4	$336K	Buy	+4,608	New	+$381K	0.42%	108
2017 Q2	–	Sell	-2,893	Closed	-$627K	–	176
2017 Q1	$627K	Buy	2,893 +277	+11%	+$39.6K	0.11%	91
2016 Q4	$242K	Sell	2,616 -102	-4%	-$11.5K	0.07%	151
2016 Q3	$367K	Hold	2,718	–	–	0.18%	85
2016 Q2	$275K	Buy	2,718 +1,937	+248%	+$240K	0.2%	69
2016 Q1	$128K	Sell	781 -51	-6%	-$10.3K	0.18%	131
2015 Q4	$272K	Buy	+832	New	+$271K	0.75%	55

Other funds holding LUMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Virtus ETF Advisers's LUMO Position: Q2 2018 in Review

Virtus ETF Advisers sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 10,061 shares — an estimated $656K sold.

Virtus ETF Advisers first reported a position in LUMO in Q4 2015 and held it in 8 quarters. The position peaked at $656K in Q1 2018. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

Virtus ETF Advisers reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Virtus ETF Advisers sold 10,061 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $656K.
Virtus ETF Advisers first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2015 and held it in 8 quarters.
Virtus ETF Advisers's Lumos Pharma, Inc. Common Stock position peaked at $656K in Q1 2018.
106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Virtus ETF Advisers's 13F filing for Q2 2018, filed 10 Aug 2018.